These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6441239)

  • 41. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility.
    Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graft versus host disease following intrauterine and exchange transfusions for rhesus haemolytic disease.
    Harte G; Payton D; Carmody F; O'Regan P; Thong YH
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):319-22. PubMed ID: 9325516
    [No Abstract]   [Full Text] [Related]  

  • 43. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rh disease: intrauterine intravascular fetal blood transfusion by cordocentesis.
    Onderoğlu L; Oncüloğlu C
    Turk J Pediatr; 1999; 41(1):61-5. PubMed ID: 10770677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rh haemolytic disease: continuing problem of management.
    Swinhoe DJ; Gilmore DH; McNay MB; Whittle MJ
    Arch Dis Child; 1990 Apr; 65(4 Spec No):365-8. PubMed ID: 2110805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma exchange in the management of severe rhesus haemolytic disease.
    Halligan A; McGuinness EP
    Ir Med J; 1990 Sep; 83(3):107-8. PubMed ID: 2121660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.
    Fox C; Martin W; Somerset DA; Thompson PJ; Kilby MD
    Fetal Diagn Ther; 2008; 23(2):159-63. PubMed ID: 18046076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intrauterine intravascular fetal transfusion under ultrasonic guide in Rh isoimmunization: a case report].
    Tanigawara S; Okamura K; Watanabe T; Endo H; Shintaku Y; Akiyama N; Iwamoto M; Shinkawa O; Yajima A; Sakai T
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):621-4. PubMed ID: 2502588
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of fetal hemolytic disease by hemosorption].
    Sergienko NS; Malinovskaia SIa; Sichinava LG
    Akush Ginekol (Mosk); 1989 Sep; (9):56-9. PubMed ID: 2512819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Intrauterine blood transfusion in severe erythrocyte stimulation. A necessary intervention but not without risks].
    Engkvist F; Wåhlin M; Axelsson O
    Lakartidningen; 2008 Nov 12-18; 105(46):3329-33. PubMed ID: 19062624
    [No Abstract]   [Full Text] [Related]  

  • 52. Consequences of fetomaternal haemorrhage after intrauterine transfusion.
    Nicolini U; Kochenour NK; Greco P; Letsky EA; Johnson RD; Contreras M; Rodeck CH
    BMJ; 1988 Nov; 297(6660):1379-81. PubMed ID: 2464380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rescue in inner space: management of Rh hemolytic disease.
    Liley HG
    J Pediatr; 1997 Sep; 131(3):340-2. PubMed ID: 9329405
    [No Abstract]   [Full Text] [Related]  

  • 54. [The first intrauterine transfusion in Poland. Current problems and new achievements in this field].
    Lozińska D
    Acta Haematol Pol; 1988; 19(3-4):193-8. PubMed ID: 3075395
    [No Abstract]   [Full Text] [Related]  

  • 55. [Diagnosis and therapy in fetuses at risk in Rh isoimmunization].
    Calda P; Zizka Z; Rezábek K; Masata J; Bendl J
    Cesk Gynekol; 1993 Dec; 58(6):278-82. PubMed ID: 8293503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ACOG Practice Bulletin No. 192: Management of Alloimmunization During Pregnancy.
    Obstet Gynecol; 2018 Mar; 131(3):e82-e90. PubMed ID: 29470342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intravascular transfusion in Rh isoimmunization and its associated problems].
    Mitsuda N; Iwata M; Yanahashi A; Ohashi K; Takagi T; Tanizawa O; Nagamine K; Kurata Y; Nakajima S; Seino Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1267-70. PubMed ID: 2120374
    [No Abstract]   [Full Text] [Related]  

  • 58. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ACOG Practice Bulletin No. 192 Summary: Management of Alloimmunization During Pregnancy.
    Obstet Gynecol; 2018 Mar; 131(3):611-612. PubMed ID: 29470338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of hysterotomy and prenatal exchange transfusion in the management of severe erythroblastosis fetalis.
    Adamsons K
    Bibl Gynaecol; 1966; 38():160-8. PubMed ID: 5950087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.